Creating and distributing additional copies is prohibited without the permission of the publisher. Contact subscriptions@latinfinance.com.

Equity Follow-ons Set to Price

Jun 21, 2012

Chile’s Cencosud and Brazil’s Brazil Pharma are set to test equity investor appetite through follow-ons pricing today. Bankers, investors and analysts expect follow-ons and some of the larger IPOs to get done. Cencosud is offering 91.3m shares in the form of ADS, a sale that would raise CLP293.06bn ($586m) at Wednesday’s CLP2,791 closing price, assuming the use of a...

To continue reading please take a free trial, subscribe or login below.


Already have an account?

Subscribe

Subscribe now for unlimited access to all current and archive news, data and market analysis. 

Subscribe

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

LatinFinance Events

Poll

Is recent bond market volatility the end of easy borrowing for LatAm issuers?

Vote    



  1. Investors prepare for rate shift
  2. No Fear on Long-Term Investment: AmBev
  3. Institutional wealth – pension funds: The next generation
  4. Turmoil threatens equity pipeline
  5. Debt investor scorecard: Beating the benchmark


Popular Searches


"[While] it’s good to build more infrastructure and increase investment, you have to be conscious about the macro effects of too big an increase in domestic demand, including of course public expenditure."

Julio Velarde, Peru central bank


Change font size: Switch to default font size Switch to medium font size Switch to large font size

All material is subject to strictly enforced copyright terms & conditions and cannot be repurposed or reproduced. © 2013 Latin American Financial Publications Inc.

Printing isn't available for this page.